Page 207 - Read Online
P. 207

Borniger. J Cancer Metastasis Treat 2019;5:23  I  http://dx.doi.org/10.20517/2394-4722.2018.107                             Page 17 of 18

               84.   Teunis MA, Kavelaars A, Voest E, Bakker JM, Ellenbroek BA, et al. Reduced tumor growth, experimental metastasis formation, and
                   angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J 20021;16:1465-7.
               85.   Peters MAM, Walenkamp AME, Kema IP, Meijer C, de Vries EGE, et al. Dopamine and serotonin regulate tumor behavior by affecting
                   angiogenesis. Drug Resist Updat 2014;17:96-104.
               86.   Ben-Shaanan TL, Azulay-Debby H, Dubovik T, Starosvetsky E, Korin B, et al. Activation of the reward system boosts innate and adaptive
                   immunity. Nat Med 2016;22:940-4.
               87.   Ben-Shaanan TL, Schiller M, Azulay-Debby H, Korin B, Boshnak N, et al. Modulation of anti-tumor immunity by the brain’s reward
                   system. Nat Commun 2018;9:2723.
               88.   Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci Lond Engl 1979; 1998;94:557-72.
               89.   Sklar LS, Anisman H. Stress and coping factors influence tumor growth. Science 1979;205:513-5.
               90.   Sklar LS, Anisman H. Social stress influences tumor growth. Psychosom Med 1980;42:347-65.
               91.   Flint TR, Janowitz T, Connell CM, Roberts EW, Denton AE, et al. Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor
                   immunity. Cell Metab 2016;24:672-84.
               92.   Oster H, Damerow S, Kiessling S, Jakubcakova V, Abraham D, et al. The circadian rhythm of glucocorticoids is regulated by a gating
                   mechanism residing in the adrenal cortical clock. Cell Metab 2006;4:163-73.
               93.   Sood AK, Bhatty R, Kamat AA, Landen CN, Han L, et al. Stress hormone-mediated invasion of ovarian cancer cells. Clin Cancer Res
                   2006;12:369-75.
               94.   Shaashua L, Shabat-Simon M, Haldar R, Matzner P, Zmora O, et al. Perioperative COX-2 and β-adrenergic blockade improves
                   metastatic biomarkers in breast cancer patients in a phase-II randomized trial. Clin Cancer Res 2017;23:4651-61.
               95.   Heiden MGV, Cantley LC, Thompson CB. Understanding the warburg effect: the metabolic requirements of cell proliferation. Science
                   2009;324:1029-33.
               96.   Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
               97.   Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927;8:519-30.
               98.   Bharadwaj S, Venkatraghavan L, Mariappan R, Ebinu J, Meng Y, et al. Serum lactate as a potential biomarker of non-glial brain tumors. J
                   Clin Neurosci 2015 Oct;22:1625-7.
               99.   Ezeoke CC, Morley JE. Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle 2015;6:287-302.
               100.  Mariappan R, Venkatraghavan L, Vertanian A, Agnihotri S, Cynthia S, et al. Serum lactate as a potential biomarker of malignancy in
                   primary adult brain tumours. J Clin Neurosci 2015;22:144-8.
               101.  Zhou L, Xie Z, Shao Z, Chen W, Xie H, et al. Modeling the relationship between baseline lactate dehydrogenase and prognosis in patients
                   with extensive-disease small cell lung cancer: a retrospective cohort study. J Thorac Dis 2018;10:1043-9.
               102.  Cortes-Campos C, Elizondo R, Carril C, Martínez F, Boric K, et al. MCT2 expression and lactate influx in anorexigenic and orexigenic
                   neurons of the arcuate nucleus. PLoS One 2013;8:e62532.
               103.  Cha SH, Lane MD. Central lactate metabolism suppresses food intake via the hypothalamic AMP kinase/malonyl-CoA signaling pathway.
                   Biochem Biophys Res Commun 2009;386:212-6.
               104.  Chance WT, Dayal R, Friend LA, James JH. Elevated blood lactate is not a primary cause of anorexia in tumor-bearing rats. Nutr Cancer
                   2004;48:174-81.
               105.  Campos CA, Bowen AJ, Schwartz MW, Palmiter RD. Parabrachial CGRP neurons control meal termination. Cell Metab 2016;23:811-20.
               106.  Carter ME, Soden ME, Zweifel LS, Palmiter RD. Genetic identification of a neural circuit that suppresses appetite. Nature 2013;503:111-4.
               107.  Roman CW, Derkach VA, Palmiter RD. Genetically and functionally defined NTS to PBN brain circuits mediating anorexia. Nat Commun
                   2016;7:11905
               108.  Han S, Soleiman MT, Soden ME, Zweifel LS, Palmiter RD. Elucidating an affective pain circuit that creates a threat memory. Cell
                   2015;162:363-74.
               109.  Campos CA, Bowen AJ, Han S, Wisse BE, Palmiter RD, et al. Cancer-induced anorexia and malaise are mediated by CGRP neurons in the
                   parabrachial nucleus. Nat Neurosci 2017;20:934-42.
               110.  De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, et al. Microbiota-generated metabolites promote metabolic benefits
                   via gut-brain neural circuits. Cell 2014;156:84-96.
               111.  Routy B, Chatelier EL, Derosa L, Duong CPM, Alou MT, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against
                   epithelial tumors. Science 2018;359:91-7.
               112.  Lakritz JR, Poutahidis T, Mirabal S, Varian BJ, Levkovich T, et al. Gut bacteria require neutrophils to promote mammary tumorigenesis.
                   Oncotarget 2015;6:9387-96.
               113.  Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol 2007;47:593-628.
               114   Mormont MC, Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer 2003;97:155-69.
               115.  Borniger JC, Walker II WH, Gaudier-Diaz MM, Stegman CJ, Zhang N, et al. Time-of-day dictates transcriptional inflammatory responses to
                   cytotoxic chemotherapy. Sci Rep 2017;7:41220.
               116.  Dycke KCGV, Nijman RM, Wackers PFK, Jonker MJ, Rodenburg W, et al. A day and night difference in the response of the hepatic
                   transcriptome to cyclophosphamide treatment. Arch Toxicol 2015;89:221-31.
               117.  Lipp A, Tank J, Trottenberg T, Kupsch A, Arnold G, et al. Sympathetic activation due to deep brain stimulation in the region of the STN.
                   Neurology 2005;65:774-5.
               118.  Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s
                   disease: a meta-analysis. Lancet Neurol 2006;5:578-88.
               119.  Bower JE, Crosswell AD, Stanton AL, Crespi CM, Winston D, et al. Mindfulness meditation for younger breast cancer survivors: a
                   randomized controlled trial. Cancer 2015;121:1231-40.
               120.  Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, et al. Prevalence, demographics, and psychological associations of sleep disruption
   202   203   204   205   206   207   208   209   210   211   212